BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Leaders in Medical Device Preclinical Research Join Forces as Surpass, Inc. Acquires LyChron


1/18/2013 9:29:58 AM

Osceola, WI – Surpass, Inc. (“Surpass”), announced today the acquisition of LyChron, LLC (“LyChron”), expanding its capacity to serve the medical device and preclinical research community. The new California entity will operate as Surpass-Silicon Valley, LLC.

Surpass President & CEO, Liann Johnson, expressed her confidence over bringing the two organizations together, “Given significant synergies in the competencies at each site, we now have the opportunity to identify best practices and implement them across the organizations to assure that our clients receive the highest quality preclinical study experience available today.”

The operating environment for Contract Research Organizations has become increasingly challenging. Johnson continued, “Globally we are facing a strained economic landscape, and our clients, medical device and biopharmaceutical companies, are dealing with regulatory uncertainties and profit erosion.” Through the acquisition, Surpass clients will benefit by leveraging the combined resources, capacity and expertise from the earliest feasibility/proof-of-concept to pivotal GLP-compliant studies.

About Surpass

Founded in 2006, Surpass is a leading preclinical Contract Research Organization offering non-GLP and GLP preclinical research studies that require surgical or interventional approaches to evaluate the safety and efficacy of medical devices, drugs, and biologics. Based in Osceola, WI, the facility serves a range of medical specialties including cardiovascular, peripheral vascular, neurovascular, wound healing, orthopedics, and general surgery. For more information please visit www.surpassinc.com.

About LyChron

LyChron was founded in 2000 by a team of scientists and physicians and provides proof-of-concept, feasibility, prototype evaluation, validation, and GLP safety preclinical studies, as well as facilitating physician and clinical training, refining study designs, and developing novel disease models. Located in Mountain View, CA, LyChron is experienced with the evaluation of medical devices, gene or cell therapies, and pharmacological agents intended for human and veterinary clinical trials and ultimate market release. For more information please visit www.lychron.com.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES